Synthesis and characterization of Co (II), Ni (II), Cu (II) and Zn (II) chelates: DFT calculations, molecular docking and biological applications

AA Helaly, AA El-Bindary, SA Elsayed - Journal of Molecular Liquids, 2023 - Elsevier
An azo dye ligand,(Z)-2-(benzo [d] thiazol-2-yl)-2-(2-p-tolylhydrazono) acetonitrile (HL) and
its Co (II)(1), Cu (II)(2), Ni (II)(3) and Zn (II)(4) chelates were synthesized and considered …

Unveiling the Therapeutic Potential of Quinazolinone Derivatives in Cancer Treatment: A Comprehensive Exploration

J Kaur, S Kaur, Muskan, N Kaur, V Kumar… - …, 2024 - Wiley Online Library
Quinazolinone derivatives have garnered attention for their diverse biological activities,
including anticancer properties. This review combines findings from 2018 to 2024, focusing …

Novel pyrimidine Schiff bases and their selenium-containing nanoparticles as dual inhibitors of CDK1 and tubulin polymerase: Design, synthesis, anti-proliferative …

S El-Kalyoubi, SA El-Sebaey, AA El-Sayed… - Journal of enzyme …, 2023 - Taylor & Francis
Nanotechnology-based strategies can overcome the limitations of conventional cancer
therapies. Hence, novel series of pyrimidine Schiff bases (4–9) were employed in the …

A comprehensive review of small molecules targeting PI3K pathway: Exploring the structural development for the treatment of breast cancer

R Dubey, A Sharma, S Gupta, GD Gupta, V Asati - Bioorganic Chemistry, 2023 - Elsevier
Cancer stands as one of the deadliest diseases, ranking second in terms of its global impact.
Despite the presence of numerous compelling theories concerning its origins, none have …

Novel Aminopyrimidine-2, 4-diones, 2-Thiopyrimidine-4-ones, and 6-Arylpteridines as Dual-Target Inhibitors of BRD4/PLK1: Design, Synthesis, Cytotoxicity, and …

S El-Kalyoubi, SA El-Sebaey, SM Elfeky… - Pharmaceuticals, 2023 - mdpi.com
Structural-based drug design and solvent-free synthesis were combined to obtain three
novel series of 5-arylethylidene-aminopyrimidine-2, 4-diones (4, 5a–c, 6a, b), 5 …

Synthesis and In Vitro Study of pyrimidine–phthalimide Hybrids As VEGFR2 Inhibitors With Antiproliferative Activity

W Shehta, F Agili, B Farag, S Youssif… - Future Medicinal …, 2023 - Taylor & Francis
Aim: Thalidomide, a once notorious sedative, is now clinically used as an antitumor agent.
We aimed to use it as a lead compound for designing pyrimidine–phthalimide hybrids …

Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors

MM Al-Sanea, HM Hafez, AAB Mohamed… - Drug Design …, 2024 - Taylor & Francis
Background In response to the urgent need for continuous discovery of new anti-proliferative
agents, a new series of quinazoline compounds 5a-r was prepared. Methods As a reference …

GC-MS profiling and evaluation of acute oral toxicity, anti-tumour, antimicrobial and antioxidant activities of Croton socotranus Balf. f. aerial parts: in-vitro, in-vivo and in …

IA Al-Hakami, A El-Shaibany… - Natural Product …, 2023 - Taylor & Francis
Croton socotranus Balf. f. shrub is widely used traditionally in Asia as an anti-infective. The
study was conducted for metabolite profiling, oral acute toxicity and antioxidant studies …